The secret realm of phase I trials in healthy volunteers

BMJ (Online)

Volumn 350, Issue , 2015, Pages

  Kimmelman, Jonathan ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ASEPTIC MENINGITIS; DEATH; DRUG INDUSTRY; DRUG RESEARCH; EDITORIAL; HEADACHE; HUMAN; PANCOLITIS; PHASE 2 CLINICAL TRIAL (TOPIC); POLICY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SOCIAL STATUS; ADVERSE DRUG REACTION; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); RISK ASSESSMENT;

CLINICAL TRIALS, PHASE I AS TOPIC; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HEALTHY VOLUNTEERS; HUMANS; RISK ASSESSMENT;

EID: 84939219905     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h3444     Document Type: Editorial

References (8)

1. Almeida L, Azevedo B, Nunes T, et al. Why healthy subjects volunteer for phase I studies and how they perceive their participation? Eur J Clin Pharmacol 2007; 63: 1085-94.
2. Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006; 355: 1018-28.
3. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148-58.
4. Decullier E, Chan AW, Chapuis F. Inadequate dissemination of phase I trials: a retrospective cohort study. PLoS Med 2009; 6: e1000034.
5. Tranter E, Peters G, Boyce M, et al. Giving monoclonal antibodies to healthy volunteers in phase 1 trials: is it safe? Br J Clin Pharmacol 2013; 76: 164-72.
6. US Congress. Food and Drug Administration Amendments Act of 2007. Public Law 2007: 115-85.
7. Hakala A, Kimmelman J, Carlisle B, et al. Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials. BMJ 2015; 350: h1116.
8. Emanuel EJ, Bedarida G, Macci K, et al. Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies. BMJ 2015; 350: h3271.